SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-030373
Filing Date
2023-08-28
Accepted
2023-08-28 16:54:54
Documents
73
Period of Report
2023-07-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1262832
2 ex31-1.htm EX-31.1 11591
3 ex31-2.htm EX-31.2 11871
4 ex32-1.htm EX-32.1 6106
5 ex32-2.htm EX-32.2 6597
  Complete submission text file 0001493152-23-030373.txt   7051489

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vtro-20230731.xsd EX-101.SCH 62089
7 XBRL CALCULATION FILE vtro-20230731_cal.xml EX-101.CAL 81187
8 XBRL DEFINITION FILE vtro-20230731_def.xml EX-101.DEF 256116
9 XBRL LABEL FILE vtro-20230731_lab.xml EX-101.LAB 495730
10 XBRL PRESENTATION FILE vtro-20230731_pre.xml EX-101.PRE 361057
67 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1077072
Mailing Address 4621 TECHNOLOGY DRIVE GOLDEN CO 80403
Business Address 4621 TECHNOLOGY DRIVE GOLDEN CO 80403 (720) 859-4120
Vitro Biopharma, Inc. (Filer) CIK: 0000793171 (see all company filings)

IRS No.: 841012042 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-41766 | Film No.: 231216866
SIC: 2836 Biological Products, (No Diagnostic Substances)